Anji Pharma (US) LLC
4Patents
4Active
4Granted
47Portfolio score
Filing activity: Sep 21, 2017 → Dec 17, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10610500B2 | Chemosensory receptor ligand-based therapies | Human Necessities | 6 | Active |
| US10603291B2 | Compositions and methods for treating metabolic disorders | Chemistry; Metallurgy | 4 | Active |
| US10668031B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 4 | Active |
| US11065215B2 | Biguanide compositions and methods of treating metabolic disorders | Human Necessities | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.